[Countermeasures and treatment for aortic acute syndrome with 2019 coronavirus disease]

Y Si1, X F Sun1, M Zhong2

  • 1Department of Vascular Surgery, Zhongshan Hospital Fudan University, Institute of Vascular Surgery Fudan University, National Clinical Research Center for Interventional Medicine, Shanghai 200032, China.

Insights

Managing patients with acute aortic syndrome during the COVID-19 pandemic presents challenges. This study offers guidance on diagnosis, transport, procedures, team protection, and follow-up for vascular surgery during the COVID-19 epidemic.

Area of Science:

  • Vascular Surgery
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic created significant health and economic challenges.
  • Managing patients with acute aortic syndrome (AAS) during the pandemic poses unique difficulties.

Purpose of the Study:

  • To address the challenges of managing AAS patients during the COVID-19 pandemic.
  • To provide guidance on critical aspects of care for vascular surgery patients in the context of COVID-19.

Main Methods:

  • Review of government documents, relevant literature, and clinical experiences from Wuhan.
  • Development of strategies for diagnosis, transportation, intervention, team protection, and postoperative care.

Main Results:

  • Identified key challenges in managing AAS patients with concomitant COVID-19.
  • Proposed practical solutions for safe and effective patient management and surgical team protection.

Conclusions:

  • Effective management strategies are crucial for vascular surgery patients during the COVID-19 pandemic.
  • This guidance aims to minimize the impact of COVID-19 on vascular emergencies and routine care.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
172
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
291
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
204
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
122
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
182
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
593